ARISE – Aggressive Reduction of Inflammation Stops Events
|ClinicalTrials.gov Identifier: NCT00066898|
Recruitment Status : Unknown
Verified September 2006 by AtheroGenics.
Recruitment status was: Active, not recruiting
First Posted : August 8, 2003
Last Update Posted : October 3, 2006
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Primary Completion Date :||No date given|
|Study Completion Date :||December 2006|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Tardif JC, McMurray JJ, Klug E, Small R, Schumi J, Choi J, Cooper J, Scott R, Lewis EF, L'Allier PL, Pfeffer MA; Aggressive Reduction of Inflammation Stops Events (ARISE) Trial Investigators. Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet. 2008 May 24;371(9626):1761-8. doi: 10.1016/S0140-6736(08)60763-1.